These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells. Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448 [TBL] [Abstract][Full Text] [Related]
25. Identification of high affinity receptors for vasoactive intestinal peptide on human lymphocytes of B cell lineage. O'Dorisio MS; Shannon BT; Fleshman DJ; Campolito LB J Immunol; 1989 May; 142(10):3533-6. PubMed ID: 2541199 [TBL] [Abstract][Full Text] [Related]
26. Identification of a VIP-specific receptor in guinea pig tenia coli. Teng BQ; Grider JR; Murthy KS Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G718-25. PubMed ID: 11518684 [TBL] [Abstract][Full Text] [Related]
27. Ac-Tyr1hGRF discriminates between VIP receptors from rat liver and intestinal epithelium. Rouyer-Fessard C; Couvineau A; Voisin T; Laburthe M Life Sci; 1989; 45(9):829-33. PubMed ID: 2549322 [TBL] [Abstract][Full Text] [Related]
28. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 1. Molecular characterization of the binding site. Luis J; Martin JM; el Battari A; Reynier M; Marvaldi J; Pichon J Eur J Biochem; 1989 Mar; 180(2):429-33. PubMed ID: 2538330 [TBL] [Abstract][Full Text] [Related]
29. Vasoactive intestinal peptide receptors in pancreas and liver. Structure-function relationship. Christophe J; Svoboda M; Waelbroeck M; Winand J; Robberecht P Ann N Y Acad Sci; 1988; 527():238-56. PubMed ID: 2839079 [TBL] [Abstract][Full Text] [Related]
30. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2. Effect of VIP on cAMP production and on cell-surface VIP-binding sites. Martin JM; Luis J; Marvaldi J; Pichon J; Pic P Eur J Biochem; 1989 Mar; 180(2):435-9. PubMed ID: 2538331 [TBL] [Abstract][Full Text] [Related]
31. Cloning and expression of the human vasoactive intestinal peptide receptor. Sreedharan SP; Robichon A; Peterson KE; Goetzl EJ Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4986-90. PubMed ID: 1675791 [TBL] [Abstract][Full Text] [Related]
32. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis. Zawilska JB; Niewiadomski P; Nowak JZ Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130 [TBL] [Abstract][Full Text] [Related]
34. Phorbol ester induces loss of VIP stimulation of adenylate cyclase and VIP-binding sites in HT29 cells. Bozou JC; Couvineau A; Rouyer-Fessard C; Laburthe M; Vincent JP; Kitabgi P FEBS Lett; 1987 Jan; 211(2):151-4. PubMed ID: 3026847 [TBL] [Abstract][Full Text] [Related]
35. Comparison of vasoactive intestinal peptide-mediated protein phosphorylation in human lymphoblasts and colonic epithelial cells. O'Dorisio MS; Campolito LB Mol Immunol; 1989 Jun; 26(6):583-90. PubMed ID: 2770750 [TBL] [Abstract][Full Text] [Related]
36. Selective photolabeling of high and low affinity binding sites for vasoactive intestinal peptide (VIP): evidence for two classes of covalent VIP-receptor complexes in intestinal cell membranes. Robichon A; Marie JC Endocrinology; 1987 Mar; 120(3):978-85. PubMed ID: 3026793 [TBL] [Abstract][Full Text] [Related]
37. Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J. Buscail L; Gourlet P; Cauvin A; De Neef P; Gossen D; Arimura A; Miyata A; Coy DH; Robberecht P; Christophe J FEBS Lett; 1990 Mar; 262(1):77-81. PubMed ID: 2156735 [TBL] [Abstract][Full Text] [Related]
38. An endothelial cell-line contains functional vasoactive intestinal polypeptide receptors: they control inwardly rectifying K+ channels. Pasyk E; Mao YK; Ahmad S; Shen SH; Daniel EE Eur J Pharmacol; 1992 Mar; 212(2-3):209-14. PubMed ID: 1318211 [TBL] [Abstract][Full Text] [Related]
39. Covalent cross-linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29). Muller JM; Luis J; Fantini J; Abadie B; Giannellini F; Marvaldi J; Pichon J Eur J Biochem; 1985 Sep; 151(2):411-7. PubMed ID: 2992966 [TBL] [Abstract][Full Text] [Related]
40. Interaction of a bovine thymic peptide extract with vasoactive intestinal peptide (VIP) receptors. Guerrero JM; Goberna R; Molinero P; Jimenez J; Calvo JR Biosci Rep; 1986 Jun; 6(6):579-84. PubMed ID: 3021253 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]